HiSiaddi is an innovative foreign trade service provider driven by technology transformation and export business. It has established a service system of “1+2+3+4=1” and can supply bovine collagen from multiple well-known original manufacturers.
As a foreign trader with independent R&D capabilities, HiSiaddi has conducted multiple rounds of factory inspections for bovine collagen manufacturers through factory technology transformation cooperation, possessing objective and in-depth understanding of different brands. It regularly analyzes various bovine collagen manufacturers for clients to help them select matching products. Below is a supplier recommendation case.
For more cross-brand and cross-model comparative analysis services, please contact HiSiaddi customer service.
The partner is NUTRILAB BioPharmaceutical Co., Ltd., headquartered in Nuremberg, Germany. With 32 years of R&D and production experience in EU high-end anti-aging powder, medical aesthetic supporting oral liquids, and joint special medical tablets, its products are sold in premium organic DM pharmacies across Germany, Swiss wellness clinics, and Austrian chain medical aesthetic institutions. Raw material access standards align with EP European Pharmacopoeia, EFSA food safety codes, TSE/BSE bovine epidemic prevention control, BRCGS, dual KOSHER & HALAL certifications, and EU clean label regulations prohibiting external flavorings, dextrin, and antioxidant additives. The enterprise maintains stable annual procurement of 32 tons of food-grade hydrolyzed bovine collagen, previously sourced exclusively from established German Gelita and French Rousselot high-purity collagen manufacturers.
Driven by surging local livestock raw material prices, production restrictions, factory MOQ increases to 8 tons per batch, and extended ocean transit times of up to 75 days, the client launched a Chinese domestic raw material substitution project to screen samples from leading domestic collagen brands. The client independently contacted five top domestic collagen manufacturers: Shengmeinuo, Jiangsu Hengxin, Jiayi Bio, Zhongtai Bio, and Shandong Kangyuan for sample delivery. A universal industry challenge emerged: sales personnel from each factory only highlighted their own brand advantages, politely refrained from slandering competitors, yet deliberately avoided disclosing core strengths, applicable scenarios, and inherent weaknesses of peer products, only unilaterally promoting their flagship models. The client could not conduct horizontal comparisons of physical and chemical parameters, raw material sources, and application compatibility across brands, receiving 7 samples from five manufacturers in total. Laboratory testing revealed compatibility defects including oral liquid precipitation, powder moisture absorption and caking, and excessive fishy odor for partial models, incurring R&D sample consumption and semi-finished product losses equivalent to 8,200 Euros and stalling material selection for nearly 50 days. Lacking a database of Chinese collagen manufacturers and product identification capabilities, the client fully entrusted foreign trade service provider HiSiaddi to neutrally dissect the five brands and complete impartial evaluation to select matching models.
Mandatory terminal product selection indicators set by the client:
1. Raw materials for oral liquids: Fresh hide-derived hydrolyzed collagen with average molecular weight 1100~1350Da; fully soluble in cold water without residues; no flocculation under long-term storage in acidic systems of pH4.8~6.0; no native bovine fishy odor with zero external additives.
2. Raw materials for joint tablets: Bovine bone-derived small-molecule collagen with ash content ≤0.7%; loose powder resistant to moisture absorption compatible with high-speed tableting production lines; no oxidative yellowing after compounding with glucosamine and vitamin C.
3. Full-batch mandatory supporting documents: Pasture traceability records, full-indicator SGS test reports, complete EU compliance documents; support flexible small-batch split production with single-batch MOQ ≤4 tons.
HiSiaddi assembled raw material engineers and EU compliance officers to conduct on-site inspections of production workshops and quality control laboratories at the five factories, collecting factory test reports and overseas export qualifications. Setting aside one-sided marketing rhetoric from manufacturers, the team neutrally analyzed the five leading brands across six dimensions: raw material source, production process, flagship model parameters, product strengths, inherent weaknesses, and applicable terminal categories, delivering complete information to the client’s German R&D department.
· Raw material base: Fresh hides sourced from designated large-scale standardized pastures; self-operated Class 100,000 clean hydrolysis workshops, long-term supplier to European and American health supplement giants.
· Flagship models: SM-N1200 (hide-sourced for oral liquid grade), SM-G1500 (bone-sourced for tablet grade).
· Product strengths: Full-gradient enzymatic hydrolysis + four-stage nanofiltration grading delivers concentrated molecular weight distribution and excellent water solubility; complete TSE/BSE traceability system with full-factory BRCGS certification.
· Weaknesses: Standard models feature a large powder angle of repose with slight moisture absorption during filling under high humidity; high MOQ for customized modification, unsuitable for flexible small-batch trial orders.
· Applicable scenarios: Mass standardized oral liquids and conventional dietary supplement tablets; incompatible with small-batch customized special medical formulations.
· Raw material base: Exclusive fresh hides and bovine leg bones from compliant quarantined pastures in northern Jiangsu; independent flexible pilot production lines reserved for on-demand process fine-tuning.
· Flagship models: HX-P125 (refined hide collagen for medical aesthetic oral liquid exclusive use), HX-G85 (low-ash bone collagen for special medical tablet exclusive use).
· Product strengths: Low-temperature biological deodorization technology, airflow-modified powder with ultra-low moisture absorption rate, ash content controllable below 0.6%; flexible split small-batch production compatible with EU clean label standards.
· Weaknesses: Limited mass production capacity with long scheduling cycles during peak seasons; less bulk spot inventory compared to Shengmeinuo.
· Applicable scenarios: High-end medical aesthetic oral liquids, special medical joint tablets, and multi-batch small-volume customized overseas orders.
· Raw material base: Fresh hides from Uruguayan grass-fed cattle imported under patented targeted enzymatic cleavage technology, focusing on ultra-high absorption small-molecule collagen.
· Flagship models: JY-800 (ultra-small-molecule hide collagen for skincare oral drinks), JY-G2000 (bone collagen for sports nutrition powder).
· Product strengths: Small-molecule proportion exceeding 80% delivers outstanding human absorption and fastest dissolution speed with superior sensory flavor performance.
· Weaknesses: Highest unit price among the five manufacturers leading to weak cost performance for mass procurement; average long-term storage stability under highly acidic formulations.
· Applicable scenarios: Luxury high-end oral beauty drinks; unsuitable for cost-controlled mass-produced tablets.
· Raw material base: Leg bones from large-scale beef cattle slaughterhouses in northwest China, specializing in bone-derived hydrolyzed collagen.
· Flagship models: ZT-G1800 (general bone collagen for economical dietary tablets), ZT-P1300 (economical hide collagen).
· Product strengths: Low mass production cost for bone collagen with abundant spot inventory and basic physical and chemical indicators meeting national standards.
· Weaknesses: Scattered raw material sources prevent full-batch refined traceability; ash content generally ranges from 1.1% to 1.5%, failing to meet the EU special medical 0.7% limit; simple deodorization process leaves trace residual meaty odor.
· Applicable scenarios: Mid-to-low-end economical health supplements, unable to meet the client’s EU special medical access standards.
· Raw material base: Scattered hides and mixed bones sourced from multiple domestic regions; mass production lines target low-cost domestic supermarket health supplement markets.
· Flagship models: KY-P general hide collagen, KY-G conventional bone collagen.
· Product strengths: Abundant spot inventory with low quotations and no rigid MOQ requirements.
· Weaknesses: Wide molecular weight distribution with high macromolecular impurity proportion; no designated pasture traceability; microbial control only complies with national standards, failing strict EU sampling inspection requirements.
· Applicable scenarios: Low-end domestic solid beverages, completely incompatible with the client’s German access specifications.
Combining the client’s two core product lines (oral liquids and joint special medical tablets), EU compliance requirements, cost control targets, and flexible small-batch monthly stocking demands, Zhongtai Bio, Shandong Kangyuan (substandard indicators), and Jiayi Bio (excess unit price leading to mass production cost overruns) were eliminated. Two mid-to-high-end brands and three flagship models were finalized, with separate product matching arrangements:
1. Model HX-P125 refined hide collagen: Exclusively for the client’s clinic anti-aging oral liquids, average molecular weight 1220Da, low-temperature deodorization for odor-free performance, instantaneous cold-water dissolution without precipitation under refrigeration for six months, fully complying with EU clean label standards.
2. Model HX-G85 low-ash bone collagen: Exclusively for joint special medical tablets, stable ash content at 0.62%, powder-modified formulation enabling smooth filling without caking in the client’s high-humidity German workshop, no browning after long-term storage when compounded with vitamin C and glucosamine.
1. Model SM-G1500 bone collagen: Core raw material for the client’s mass-market joint dietary tablets, complete traceability documents, abundant spot inventory, and lower mass production costs than imported raw materials, with physical and chemical indicators meeting EP Pharmacopoeia standards suitable for monthly bulk replenishment.
HiSiaddi coordinated simultaneous delivery of SGS test reports, pasture traceability documents, and valid KOSHER & HALAL certifications for the three selected models from both factories, dispatching unified 5kg full-indicator samples to the client’s German R&D laboratory and tracking the full testing and formulation compatibility verification process.
After 38 days of laboratory formulation testing and small-batch pilot production, all three models fully passed NUTRILAB’s German full-indicator acceptance: HX-P125 delivered clear oral liquid finished products free of suspended matter; HX-G85 enabled smooth tablet filling without caking and no yellowing after six months of normal-temperature storage; SM-G1500 mass-produced tablet indicators fully matched the original European imported raw materials. The client finalized a split delivery plan for the annual 32-ton procurement volume:
1. Jiangsu Hengxin Bio: 14 tons annually (8 tons HX-P125 oral liquid raw materials; 6 tons HX-G85 special medical tablet raw materials), split into 12 small batches for monthly production scheduling with a single-batch MOQ of 3 tons.
2. Anhui Shengmeinuo Bio: 18 tons annually (SM-G150), delivered in 6 bulk spot batches.
The first combined shipment of 5.2 tons of raw materials departed Shanghai Port for Hamburg Port. HiSiaddi pre-reviewed full EU customs clearance documents (certificate of origin, TSE risk-free statements, batch-by-batch traceability archives, bilingual Chinese-English COA test reports), enabling one-time customs clearance without inspection upon arrival in Germany. Raw materials were delivered to the client’s full production lines for smooth operation, launching the new product whose release had been delayed by 50 days as scheduled. Compared with previous German and French imported raw materials, the client’s overall raw material procurement cost decreased by 27.2%, and ocean transit time was shortened from 75 days to 36 days.
1. German NUTRILAB fully terminated cooperation with local European collagen suppliers, switching 100% of its annual 32-ton collagen supply to Chinese sources coordinated by HiSiaddi. In the following year, the client added customized ultra-fine collagen for post-operative repair, placing an additional annual procurement order of 11.8 tons. Meanwhile, the client fully entrusted HiSiaddi with exclusive management of all Chinese procurement of raw materials including fish collagen and soybean oligopeptides.
2. Supported by the successful delivery of this neutral supplier selection project, Hengxin and Shengmeinuo secured three additional mid-to-high-end EU nutrition brand clients in the Netherlands and Belgium leveraging the German brand endorsement.
Driven by sales performance targets, leading domestic collagen manufacturers only highlight their own product advantages and avoid disclosing peer strengths during external promotion, creating information barriers for overseas mid-to-high-end clients conducting independent supplier selection. Blind sample testing easily leads to raw material misselection, formulation scrapping, and R&D losses. European and American high-end pharmaceutical and medical aesthetic brands lack databases of Chinese collagen manufacturers and cannot distinguish process differences and applicable boundaries across various brands and models. Breaking the traditional foreign trade model limited to quotation and order taking, HiSiaddi operates as a neutral third-party raw material selection service provider, horizontally dissecting advantages and disadvantages of multiple brands objectively and accurately screening products aligned with clients’ terminal formulation demands. It helps clients avoid unnecessary sample testing losses, shorten material selection cycles, and achieve localized cost reduction, while enabling high-quality mid-to-high-end domestic collagen manufacturers to escape low-price competition and stably access high-value EU raw material supply chains, realizing long-term win-win cooperation for both supply and demand sides.
For more cross-brand and cross-model comparative analysis services, please contact HiSiaddi customer service.
+86-13120989737 
info@hisiaddi.com 
English
